Literature DB >> 11451931

Circulating transforming growth factor-beta(1): a potential marker of disease activity during idiopathic pulmonary fibrosis.

S J Yong1, A Adlakha, A H Limper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11451931     DOI： 10.1378/chest.120.1_suppl.s68

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  7 in total

1.  Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis.

Authors:  Li Zhang; Xiao-Hong Fu; Yong Yu; Ruo-Hong Shui; Chun Li; Hai-Ying Zeng; Yu-Lei Qiao; Li-Yan Ni; Qiang Wang
Journal:  Lab Invest       Date:  2014-11-10       Impact factor: 5.662

2.  TGF-β1 T869C polymorphism may affect susceptibility to idiopathic pulmonary fibrosis and disease severity.

Authors:  Ji Young Son; Song Yee Kim; Sang Ho Cho; Hyo Sub Shim; Ji-Ye Jung; Eun Young Kim; Ju Eun Lim; Byung Hoon Park; Young Ae Kang; Young Sam Kim; Se Kyu Kim; Joon Chang; Moo Suk Park
Journal:  Lung       Date:  2013-01-24       Impact factor: 2.584

3.  Transforming growth factor beta 1 activation, storage, and signaling pathways in idiopathic pulmonary fibrosis in dogs.

Authors:  E Krafft; P Lybaert; E Roels; H P Laurila; M M Rajamäki; F Farnir; M Myllärniemi; M J Day; K Mc Entee; C Clercx
Journal:  J Vet Intern Med       Date:  2014-10-20       Impact factor: 3.333

4.  Aberrant B Cell Receptor Signaling in Naïve B Cells from Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Stefan F H Neys; Peter Heukels; Jennifer A C van Hulst; Jasper Rip; Marlies S Wijsenbeek; Rudi W Hendriks; Odilia B J Corneth
Journal:  Cells       Date:  2021-05-26       Impact factor: 6.600

5.  Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis.

Authors:  Esam H Alhamad; Joseph G Cal; Zahid Shakoor; Adel Almogren; Ahmad A AlBoukai
Journal:  BMC Med Genet       Date:  2013-07-01       Impact factor: 2.103

6.  Reassessing the Role of the Active TGF-β1 as a Biomarker in Systemic Sclerosis: Association of Serum Levels with Clinical Manifestations.

Authors:  Andréa Tavares Dantas; Sayonara Maria Calado Gonçalves; Anderson Rodrigues de Almeida; Rafaela Silva Guimarães Gonçalves; Maria Clara Pinheiro Duarte Sampaio; Kamila de Melo Vilar; Michelly Cristiny Pereira; Moacyr Jesus Barreto de Melo Rêgo; Ivan da Rocha Pitta; Claudia Diniz Lopes Marques; Angela Luzia Branco Pinto Duarte; Maira Galdino da Rocha Pitta
Journal:  Dis Markers       Date:  2016-11-14       Impact factor: 3.434

7.  A Rnd3/p190RhoGAP pathway regulates RhoA activity in idiopathic pulmonary fibrosis fibroblasts.

Authors:  Elizabeth Monaghan-Benson; Erika S Wittchen; Claire M Doerschuk; Keith Burridge
Journal:  Mol Biol Cell       Date:  2018-07-11       Impact factor: 4.138
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.